PerkinElmer Launches the SmartStation Integrated Platform and Five New Drug Discovery Offerings
Products to be Showcased at the Conference for the Society for Biomolecular Screening (SBS)
25-Sep-2002 -
BOSTON, Sep 23, 2002 -- PerkinElmer, a leading provider of drug discovery, life science research and genetic disease screening solutions, will showcase its new SmartStation(TM) Integrated Platform and five additional drug discovery solutions at the Conference for the Society for Biomolecular ...
apoptosis
cytotoxicity
density
+11